Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2006 (Vol. 26, No. 7)

The Society for the Study of Evolution

  • Educational content
  • Needs less space devoted to the society
I’ll be glad when the day comes that the principles of evolution are accepted routinely by non-scientists, just like the acceptance the Intelligent Designers have for scientific advancements like medicine, iPods, and the Internet. Until that happens, however, it is important for scientists to stay on top of this topic and lend support wherever they can. In that direction, The Society for the Study of Evolution stands as an important icon. Founded in 1946, the society hosts a site mostly dedicated to the workings and mechanics of the organization, but a few sections of the site are of more general interest. They include educational resources for K-12, links to other resources, a white paper on evolutionary biology (excellently written), and important statements on the study and teaching of evolution. A welcome set of resources from a very reputable source.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »